Industry Insights · Regulatory · Registration · Quality
Medical-device 'product realization' elements: the quality chain from design to release
A quality system must land on the product, and 'product realization' is the stretch that turns quality from idea into executable action.
What product realization covers
- Planning: quality objectives, processes, documents and acceptance criteria, with risk management;
- Design and development: inputs–outputs–review–verification–validation–design transfer–change control, a closed loop;
- Purchasing: supplier evaluation/re-evaluation, clear purchasing info, incoming verification;
- Production and service: process validation (especially special processes like sterilization), identification and traceability, preservation;
- Control of monitoring/measuring equipment: calibration and status management of instruments.
Why traceability is stressed
If a device has a problem, it must be located and recalled fast, so material lots, production records and release testing must all be traceable. Traceability isn't a burden but the basis of risk control and fast response.
Design transfer and change control
Transferring a design into a spec that produces consistently, and controlling later changes, is the most underrated yet consistency-defining part of product realization.
The BIO angle
FAQ
What does 'product realization' cover?
Planning, customer-related processes, design and development, purchasing, production and service provision, and control of monitoring/measuring equipment — a chain from design to release.
Why is traceability stressed for devices?
To locate, recall and correct problems fast; end-to-end traceability from material lot to release testing underpins risk control.
Why does design transfer matter?
It turns a design into a spec that produces consistently, directly determining how well mass product matches the design — an underrated key step.
Related reading
- FDA UDI: Labeler, DI/PI, GUDID & Direct-Marking Boundaries | BIO
- Reading ISO 13485 Through PDCA: the Logic Behind the Quality System | BIO Insights
- Medical-Device Biological Evaluation: A Risk-Based Evidence Route | BIO
Note: an original analysis compiled from public industry information; figures and conclusions per official/original sources. Not investment advice.
Building in China's medical-device market?
From advanced medical silicone/polymers to material selection, regulatory and supply, BIO helps global and local partners move from selection to landed supply in China.